Manulife (Manufacturers Life Insurance)’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Buy |
39,313
+28,410
| +261% | +$1.38M | ﹤0.01% | 1517 |
|
|
2025
Q1 | $371K | Sell |
10,903
-1,387
| -11% | -$47.2K | ﹤0.01% | 2270 |
|
|
2024
Q4 | $484K | Sell |
12,290
-187
| -1% | -$7.36K | ﹤0.01% | 2259 |
|
|
2024
Q3 | $586K | Buy |
12,477
+231
| +2% | +$10.9K | ﹤0.01% | 2196 |
|
|
2024
Q2 | $661K | Sell |
12,246
-8,126
| -40% | -$439K | ﹤0.01% | 2083 |
|
|
2024
Q1 | $1.39M | Sell |
20,372
-9,149
| -31% | -$624K | ﹤0.01% | 1669 |
|
|
2023
Q4 | $1.85M | Buy |
29,521
+128
| +0.4% | +$8.01K | ﹤0.01% | 1492 |
|
|
2023
Q3 | $1.33M | Buy |
29,393
+6,985
| +31% | +$317K | ﹤0.01% | 1587 |
|
|
2023
Q2 | $1.26M | Buy |
22,408
+1,929
| +9% | +$108K | ﹤0.01% | 1553 |
|
|
2023
Q1 | $926K | Buy |
20,479
+161
| +0.8% | +$7.28K | ﹤0.01% | 1679 |
|
|
2022
Q4 | $820K | Buy |
20,318
+527
| +3% | +$21.3K | ﹤0.01% | 1711 |
|
|
2022
Q3 | $1.28M | Sell |
19,791
-48
| -0.2% | -$3.1K | ﹤0.01% | 1507 |
|
|
2022
Q2 | $1.25M | Buy |
19,839
+4,040
| +26% | +$254K | ﹤0.01% | 1551 |
|
|
2022
Q1 | $1.01M | Buy |
+15,799
| New | +$1.01M | ﹤0.01% | 1745 |
|